US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 27.630
  • +2.200+8.65%
Close Nov 6 16:00 ET
  • 27.630
  • 0.0000.00%
Post 17:24 ET
1.83BMarket Cap-10047P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
832.09%2.5M
-83.87%156K
192.02%6.88M
156.11%4.13M
272.73%1.52M
64.42%268K
455.75%967K
-49.32%2.36M
382.93%1.61M
166.01%407K
Operating revenue
832.09%2.5M
-83.87%156K
192.02%6.88M
156.11%4.13M
272.73%1.52M
64.42%268K
455.75%967K
-49.32%2.36M
382.93%1.61M
166.01%407K
Cost of revenue
Gross profit
Operating expense
45.83%48.82M
21.91%40.76M
36.06%148.93M
33.09%39.26M
52.14%42.76M
20.04%33.47M
39.52%33.44M
48.31%109.45M
41.01%29.5M
45.03%28.1M
Selling and administrative expenses
26.41%9.13M
37.09%9.1M
13.68%30.91M
33.84%8.83M
25.88%8.22M
0.94%7.22M
-3.92%6.64M
32.74%27.2M
5.74%6.6M
12.20%6.53M
-General and administrative expense
26.41%9.13M
37.09%9.1M
13.68%30.91M
33.84%8.83M
25.88%8.22M
0.94%7.22M
-3.92%6.64M
32.74%27.2M
5.74%6.6M
12.20%6.53M
Research and development costs
51.18%39.69M
18.15%31.66M
43.46%118.01M
32.87%30.43M
60.09%34.54M
26.63%26.25M
57.12%26.8M
54.30%82.26M
56.01%22.9M
59.12%21.57M
Operating profit
-39.49%-46.32M
-25.06%-40.61M
-32.63%-142.04M
-25.97%-35.13M
-48.90%-41.24M
-19.78%-33.21M
-36.47%-32.47M
-54.88%-107.1M
-35.46%-27.89M
-44.06%-27.7M
Net non-operating interest income expense
Other net income (expense)
287.53%10.48M
150.80%7.8M
111.72%613K
-685.05%-8.18M
226.64%2.98M
132.64%2.7M
318.57%3.11M
-228.87%-5.23M
219.91%1.4M
162.72%912K
Gain on sale of security
287.53%10.48M
150.80%7.8M
350.77%13.11M
209.08%4.32M
226.64%2.98M
589.54%2.7M
1,402.42%3.11M
476.04%2.91M
628.13%1.4M
528.97%912K
Special income (charges)
----
----
-53.60%-12.5M
---12.5M
--0
----
----
-288.45%-8.14M
--0
--0
-Less：Restructuring and merger&acquisition
----
----
--0
--0
--0
----
----
-388.40%-6.86M
--0
--0
-Less:Impairment of capital assets
----
----
--0
----
----
----
----
--0
----
----
-Less:Other special charges
----
----
-16.67%12.5M
----
----
----
----
--15M
--0
----
Income before tax
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-58.79%-112.33M
-31.46%-26.49M
-29.52%-26.78M
Income tax
0
0
Net income
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-59.30%-112.33M
-31.46%-26.49M
-30.96%-26.78M
Net income continuous Operations
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-59.30%-112.33M
-31.46%-26.49M
-30.96%-26.78M
Minority interest income
Net income attributable to the parent company
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-59.30%-112.33M
-31.46%-26.49M
-30.96%-26.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-17.51%-35.84M
-11.74%-32.81M
-25.91%-141.43M
-63.50%-43.31M
-42.85%-38.26M
15.28%-30.5M
-27.38%-29.36M
-59.30%-112.33M
-31.46%-26.49M
-30.96%-26.78M
Basic earnings per share
16.92%-0.54
9.68%-0.56
-21.67%-2.92
-50.00%-0.84
-42.11%-0.81
15.58%-0.65
-26.53%-0.62
-46.34%-2.4
-30.23%-0.56
-26.67%-0.57
Diluted earnings per share
16.92%-0.54
9.68%-0.56
-21.67%-2.92
-50.00%-0.84
-42.11%-0.81
15.58%-0.65
-26.53%-0.62
-46.34%-2.4
-30.23%-0.56
-26.67%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022 (Q3)Sep 30, 2022
Total revenue 832.09%2.5M -83.87%156K 192.02%6.88M 156.11%4.13M 272.73%1.52M 64.42%268K 455.75%967K -49.32%2.36M 382.93%1.61M 166.01%407K
Operating revenue 832.09%2.5M -83.87%156K 192.02%6.88M 156.11%4.13M 272.73%1.52M 64.42%268K 455.75%967K -49.32%2.36M 382.93%1.61M 166.01%407K
Cost of revenue
Gross profit
Operating expense 45.83%48.82M 21.91%40.76M 36.06%148.93M 33.09%39.26M 52.14%42.76M 20.04%33.47M 39.52%33.44M 48.31%109.45M 41.01%29.5M 45.03%28.1M
Selling and administrative expenses 26.41%9.13M 37.09%9.1M 13.68%30.91M 33.84%8.83M 25.88%8.22M 0.94%7.22M -3.92%6.64M 32.74%27.2M 5.74%6.6M 12.20%6.53M
-General and administrative expense 26.41%9.13M 37.09%9.1M 13.68%30.91M 33.84%8.83M 25.88%8.22M 0.94%7.22M -3.92%6.64M 32.74%27.2M 5.74%6.6M 12.20%6.53M
Research and development costs 51.18%39.69M 18.15%31.66M 43.46%118.01M 32.87%30.43M 60.09%34.54M 26.63%26.25M 57.12%26.8M 54.30%82.26M 56.01%22.9M 59.12%21.57M
Operating profit -39.49%-46.32M -25.06%-40.61M -32.63%-142.04M -25.97%-35.13M -48.90%-41.24M -19.78%-33.21M -36.47%-32.47M -54.88%-107.1M -35.46%-27.89M -44.06%-27.7M
Net non-operating interest income expense
Other net income (expense) 287.53%10.48M 150.80%7.8M 111.72%613K -685.05%-8.18M 226.64%2.98M 132.64%2.7M 318.57%3.11M -228.87%-5.23M 219.91%1.4M 162.72%912K
Gain on sale of security 287.53%10.48M 150.80%7.8M 350.77%13.11M 209.08%4.32M 226.64%2.98M 589.54%2.7M 1,402.42%3.11M 476.04%2.91M 628.13%1.4M 528.97%912K
Special income (charges) ---- ---- -53.60%-12.5M ---12.5M --0 ---- ---- -288.45%-8.14M --0 --0
-Less：Restructuring and merger&acquisition ---- ---- --0 --0 --0 ---- ---- -388.40%-6.86M --0 --0
-Less:Impairment of capital assets ---- ---- --0 ---- ---- ---- ---- --0 ---- ----
-Less:Other special charges ---- ---- -16.67%12.5M ---- ---- ---- ---- --15M --0 ----
Income before tax -17.51%-35.84M -11.74%-32.81M -25.91%-141.43M -63.50%-43.31M -42.85%-38.26M 15.28%-30.5M -27.38%-29.36M -58.79%-112.33M -31.46%-26.49M -29.52%-26.78M
Income tax 0 0
Net income -17.51%-35.84M -11.74%-32.81M -25.91%-141.43M -63.50%-43.31M -42.85%-38.26M 15.28%-30.5M -27.38%-29.36M -59.30%-112.33M -31.46%-26.49M -30.96%-26.78M
Net income continuous Operations -17.51%-35.84M -11.74%-32.81M -25.91%-141.43M -63.50%-43.31M -42.85%-38.26M 15.28%-30.5M -27.38%-29.36M -59.30%-112.33M -31.46%-26.49M -30.96%-26.78M
Minority interest income
Net income attributable to the parent company -17.51%-35.84M -11.74%-32.81M -25.91%-141.43M -63.50%-43.31M -42.85%-38.26M 15.28%-30.5M -27.38%-29.36M -59.30%-112.33M -31.46%-26.49M -30.96%-26.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -17.51%-35.84M -11.74%-32.81M -25.91%-141.43M -63.50%-43.31M -42.85%-38.26M 15.28%-30.5M -27.38%-29.36M -59.30%-112.33M -31.46%-26.49M -30.96%-26.78M
Basic earnings per share 16.92%-0.54 9.68%-0.56 -21.67%-2.92 -50.00%-0.84 -42.11%-0.81 15.58%-0.65 -26.53%-0.62 -46.34%-2.4 -30.23%-0.56 -26.67%-0.57
Diluted earnings per share 16.92%-0.54 9.68%-0.56 -21.67%-2.92 -50.00%-0.84 -42.11%-0.81 15.58%-0.65 -26.53%-0.62 -46.34%-2.4 -30.23%-0.56 -26.67%-0.57
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- Unqualified Opinion -- -- -- -- -- -- --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data